Total Payments
$3,171
2024 Payments
$476.69
Companies
27
Transactions
147
Medicare Patients
2,757
Medicare Billing
$801,907
Payment Breakdown by Category
Food & Beverage$2,859 (90.2%)
Education$311.65 (9.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,859 | 143 | 90.2% |
| Education | $311.65 | 4 | 9.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $647.48 | 37 | $0 (2024) |
| ViiV Healthcare Company | $536.67 | 23 | $0 (2024) |
| Octapharma USA, Inc. | $392.18 | 14 | $0 (2024) |
| Astellas Pharma US Inc | $250.49 | 8 | $0 (2024) |
| Janssen Products, LP | $198.95 | 2 | $0 (2019) |
| AbbVie Inc. | $161.95 | 7 | $0 (2023) |
| Merck Sharp & Dohme LLC | $134.16 | 8 | $0 (2023) |
| Janssen Biotech, Inc. | $105.96 | 7 | $0 (2019) |
| Allergan Inc. | $89.72 | 6 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $75.85 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $476.69 | 23 | ViiV Healthcare Company ($117.23) |
| 2023 | $559.08 | 26 | Gilead Sciences, Inc. ($132.85) |
| 2022 | $503.12 | 18 | Octapharma USA, Inc. ($213.65) |
| 2021 | $213.10 | 10 | Gilead Sciences, Inc. ($107.23) |
| 2020 | $52.55 | 3 | ViiV Healthcare Company ($24.72) |
| 2019 | $633.11 | 27 | Gilead Sciences, Inc. ($165.77) |
| 2018 | $264.97 | 15 | ViiV Healthcare Company ($47.08) |
| 2017 | $468.16 | 25 | Janssen Products, LP ($99.00) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: Infectious Diseases | ||||||
| 10/22/2024 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.65 | General |
| 09/17/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: ANTIBIOTIC | ||||||
| 09/10/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: HIV | ||||||
| 08/22/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: IMMUNOLOGY | ||||||
| 07/30/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: GI | ||||||
| 07/16/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: ANTIBIOTIC | ||||||
| 07/02/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA, CUTAQUIG | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: IMMUNOLOGY | ||||||
| 06/04/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Infectious Diseases | ||||||
| 05/31/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: HIV | ||||||
| 05/28/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/23/2024 | Octapharma USA, Inc. | PANZYGA (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
| 04/11/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: HIV | ||||||
| 03/13/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $30.12 | General |
| Category: HIV | ||||||
| 02/08/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Infectious Diseases | ||||||
| 02/06/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: HIV | ||||||
| 01/11/2024 | Octapharma USA, Inc. | CUTAQUIG (Biological) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: IMMUNOLOGY | ||||||
| 01/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.24 | General |
| 01/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.46 | General |
| 11/16/2023 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $27.94 | General |
| Category: Infectious Diseases | ||||||
| 10/17/2023 | Octapharma USA, Inc. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 443 | 902 | $217,456 | $66,680 |
| 2022 | 15 | 557 | 1,911 | $420,139 | $132,323 |
| 2021 | 15 | 563 | 2,068 | $1.0M | $285,474 |
| 2020 | 16 | 1,194 | 2,863 | $792,969 | $317,430 |
Total Patients
2,757
Total Services
7,744
Medicare Billing
$801,907
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96521 | Refilling and maintenance of portable pump | Office | 2023 | 17 | 237 | $88,875 | $25,364 | 28.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 86 | 88 | $39,600 | $11,857 | 29.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 107 | $19,260 | $7,097 | 36.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 45 | 98 | $14,210 | $6,173 | 43.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 57 | 114 | $9,690 | $4,453 | 46.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 34 | $7,140 | $3,252 | 45.6% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 14 | 29 | $3,520 | $2,403 | 68.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $6,700 | $2,033 | 30.3% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 75 | 82 | $20,455 | $2,012 | 9.8% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 63 | $4,406 | $1,100 | 25.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 30 | 30 | $3,600 | $937.14 | 26.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Office | 2022 | 17 | 259 | $97,405 | $27,499 | 28.2% |
| 96521 | Refilling and maintenance of portable pump | Office | 2022 | 12 | 174 | $65,250 | $20,719 | 31.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 90 | 95 | $42,750 | $14,420 | 33.7% |
| 29581 | Application of vein wound compression bandages on lower leg, ankle, and foot | Office | 2022 | 13 | 255 | $45,900 | $14,241 | 31.0% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 110 | 116 | $31,320 | $10,103 | 32.3% |
| 97597 | Removal of tissue from wound, 20.0 sq cm or less | Office | 2022 | 15 | 117 | $32,409 | $10,014 | 30.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 22 | 421 | $29,401 | $8,090 | 27.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 137 | $19,155 | $7,496 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 87 | $15,660 | $5,686 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 60 | $12,600 | $4,629 | 36.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 45 | 90 | $7,650 | $2,722 | 35.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 21 | $7,035 | $2,203 | 31.3% |
| 97163 | Evaluation for physical therapy, typically 45 minutes | Office | 2022 | 16 | 21 | $3,850 | $1,722 | 44.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 33 | 36 | $4,331 | $1,159 | 26.8% |
About Dr. Jack Bissett, M.D
Dr. Jack Bissett, M.D is a Infectious Disease healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407874027.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jack Bissett, M.D has received a total of $3,171 in payments from pharmaceutical and medical device companies, with $476.69 received in 2024. These payments were reported across 147 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,859).
As a Medicare-enrolled provider, Bissett has provided services to 2,757 Medicare beneficiaries, totaling 7,744 services with total Medicare billing of $801,907. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Austin, TX
- Active Since 07/18/2006
- Last Updated 07/13/2010
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1407874027
Products in Payments
- DOVATO (Drug) $309.26
- AVYCAZ (Drug) $166.90
- PREZCOBIX (Drug) $151.21
- CUTAQUIG (Biological) $144.36
- PANZYGA (Biological) $140.02
- Cresemba (Drug) $134.51
- Symtuza (Drug) $115.44
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Biological) $96.24
- VIBATIV (Drug) $88.99
- LIVTENCITY (Drug) $75.85
- Baxdela (Drug) $73.38
- TROGARZO (Drug) $59.94
- TRIUMEQ (Drug) $56.26
- ISENTRESS (Drug) $53.09
- RUKOBIA (Drug) $51.01
- SEROSTIM (Drug) $50.18
- APRETUDE (Biological) $48.16
- CABENUVA (Biological) $48.02
- Daraprim Tablet 25mg (Drug) $46.64
- DALVANCE (Drug) $42.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Austin
Brian Metzger, Md, MD
Infectious Disease — Payments: $154,701
Infectious Disease $154,701
James Evans, M.d, M.D
Infectious Disease — Payments: $5,710
Infectious Disease $5,710
Lisa Ellis, M.d, M.D
Infectious Disease — Payments: $2,163
Infectious Disease $2,163
Kristin Mondy, Md, MD
Infectious Disease — Payments: $646.53
Infectious Disease $646.53
Stephanie Cobb, D.o, D.O
Infectious Disease — Payments: $562.91
Infectious Disease $562.91
Dr. Jennifer Shuford, M.d, M.D
Infectious Disease — Payments: $152.24
Infectious Disease $152.24